ANI Plans To Shutter Oakville Plant By Q1 2023

Action Part Of Ongoing Efforts To Consolidate Manufacturing Network

 
• By Chloe Kent

ANI Pharmaceuticals has announced the closure of its Oakville, Ontario manufacturing plant, a move which is expected to save the firm $7m to $8m.

ANI Pharmaceuticals Canada head office in Oakville
ANI is now seeking to sell its Oakville facility • Source: Shutterstock

More from Strategy

More from Business